Skip to main content
SpringerLink
Log in

Impact of Cefotaxime and Ceftriaxone on the Bowel and Vaginal Flora after Single-Dose Prophylaxis in Vaginal Hysterectomy

  • Section 4: Further Clinical Experiences and Studies of Tolerability with Cefotaxime
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The aim of this randomised controlled study was to investigate the effect of a preoperative, single dose, intravenous injection of ceftriaxone 2g and cefotaxime 2g in 2 groups of 30 patients who underwent vaginal hysterectomy. The parameters were: efficacy and tolerance; impact on the aerobic bowel and vaginal flora; and serum concentrations. There were no significant differences in efficacy, haematology or clinical chemistry parameters. In the ceftriaxone group 2 patients had exanthemas, 2 had diarrhoea. In the cefotaxime group no such side effects occurred. Serum concentrations were 9.75 and 0.07 mg/L for ceftriaxone and cefotaxime, respectively, after 24 arid 12 hours, respectively. Ceftriaxone had a pronounced and continuous effect on the bowel flora: Streptococcus faeciurn and Candida spp. increased, reaching counts of 108 and 107 organisms/g faeces, respectively, at day 10. Under cefotaxime no dramatic alteration was determined and growth of Candida spp. was not influenced. Growth of Escherichia coli and other bacteria of the vaginal flora was not influenced by either drug. Overgrowth of Candida spp. under ceftriaxone was significant (p <0.05) compared with that under cefotaxime. The results of this study indicate that the high biliary excretion of ceftriaxone (45%) and its long acting properties are responsible for the high selection pressure and overgrowth of Candida. Cefotaxime, a drug with low biliary excretion (5%) and shorter action, had only a negligible effect on the microflora with quick normalisation. The observed overgrowth of Candida spp., even after a single injection of ceftriaxone, could cause problems when this drug is being used for surgical prophylaxis or treatment. This applies especially to immunocompromised patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Barson WJ, et al. Prospective comparative trial of ceftriaxone vs conventional therapy for treatment of bacterial meningitis in children. Pediatric Infectious Disease 4: 362–368, 1985

    Article  PubMed  CAS  Google Scholar 

  • Baumgartner J-D, Glauser MP. Tolerance study of ceftriaxone compared with amoxicillin in patients with pneumonia. American Journal of Medicine 77 (Suppl. 4C): 54–58, 1984

    PubMed  CAS  Google Scholar 

  • Bergan T. Pharmacokinetics of beta-lactam antibiotics. Scandinavian Journal of Infectious Diseases (Suppl.) 42: 93–98, 1984

    Google Scholar 

  • Blanco JD, Lipscomb KA. Single-dose prophylaxis in vaginal hysterectomy: a double-blind, randomized comparison of ceftazidime versus cefotaxime. Current Therapeutic Research 36: 389–393, 1984

    Google Scholar 

  • Childs SJ, Wells WG, Mirelman S. Ceftriaxone for once-a-day therapy of urinary tract infections. American Journal of Medicine 77 (Suppl. 4C): 73–76, 1984

    PubMed  CAS  Google Scholar 

  • Congeni BL, et al. Proceedings of the 9th International Congress of Infectious and Parasitic Diseases, Munich, July 2026, 1986. Abstract 298, 1986

  • Del Rio Maria de los A, Chrane D, Shelton S, McCracken GH Jr, Nelson JD. Ceftriaxone versus ampicillin and chloram-phenicol for treatment of bacterial meningitis in children. Lancet 8336: 1241–1244, 1983

    Google Scholar 

  • DiPiro JT, Cheung RPF, Bowden TA, Mansberger JA. Single dose systemic antibiotic prophylaxis of surgical wound infections. American Journal of Surgery 152: 552–559, 1986

    Article  Google Scholar 

  • Eron LJ, et al. Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings. Antimicrobial Agents and Chemotherapy 23: 731–737, 1983

    Article  PubMed  CAS  Google Scholar 

  • Fischbach F, et al. Changes in the vaginal microbiological flora and infectious morbidity rate following vaginal hysterectomy and antibiotic prophylaxis. 2nd European Congress of Clinical Microbiology, Brighton, Sept. 1–5, 1985. Abstract 1817, 1985

  • Gonik B. Singleversus three-dose cefotaxime prophylaxis for cesarian section. Obstetrics and Gynecology 65: 189–193, 1985

    PubMed  CAS  Google Scholar 

  • Guggenbichler JP, et al. Influence of cephalosporins III generation with varying biliary elimination on fecal flora and emergence of resistant bacteria during therapy. Proceedings of the 14th International Congress of Chemotherapy, Kyoto, 2607–2608, 1985

  • Haegele D, Berg D. Perioperative Infektionsprophylaxe mit Cefotaxim. Geburtshilfe und Frauenheilkunde 45: 40–42, 1985

    Article  Google Scholar 

  • Hale DC, Tanner M. Comparison of cefoperazone (CP) with cefotaxime (CT) for prophylaxis of vaginal hysterectomy. 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, 8–10 Oct. 1984, Washington, D.C. Abstract 1161, p. 296, 1984

  • Harding SM. Pharmacokinetics of the third-generation cephalosporins. The American Journal of Medicine 79 (Suppl. 2A): 21–24, 1985

    Article  PubMed  CAS  Google Scholar 

  • Harrison ChJ, et al. Ceftriaxone therapy in pediatric patients. American Journal of Diseases of Children 137: 1048–1051, 1983

    PubMed  CAS  Google Scholar 

  • Heard ML, et al. Susceptibility profiles of potential aerobic and anaerobic pathogens isolated from hysterectomy patients. American Journal of Obstetrics and Gynecology 149: 133–143, 1984

    PubMed  CAS  Google Scholar 

  • Hemsell DL. Antimicrobial prophylaxis for vaginal hysterectomy. Journal of Obstetrics and Gynecology 6 (Suppl. 1): S66–S68, 1986

    Article  Google Scholar 

  • Hemsell DL, et al. Ceftriaxone or cefazolin prophylaxis for the prevention of infection after vaginal hysterectomy. American Journal of Surgery 148 (Suppl.4A): 22–26, 1984

    PubMed  CAS  Google Scholar 

  • Hemsell DL, et al. Ceftriaxone and cefazolin prophylaxis for hysterectomy. Surgery, Gynecology and Obstetrics 161: 197–203, 1985

    PubMed  CAS  Google Scholar 

  • Higham M, et al. Ceftriaxone administered once or twice a day for treatment of bacterial infections of childhood. Pediatric Infectious Disease 4: 22–26, 1985

    Article  PubMed  CAS  Google Scholar 

  • Hirsch HA. Prophylactic antibiotics in obstetrics and gynecology. The American Journal of Medicine 78 (Suppl. 6B): 170–176, 1985

    Article  PubMed  CAS  Google Scholar 

  • Iwata S, et al. The influence of new cephems on the intestinal flora. Proceedings of the 14th International Congress of Chemotherapy, Kyoto, 2603–2604, 1985

  • Knothe H, et al. Impact of injectable cephalosporins on the gastrointestinal microflora: observations in healthy volunteers and hospitalized patients. Infection 13 (Suppl. 1): S129–S133, 1985

    Article  PubMed  Google Scholar 

  • Krause R, et al. Investigation of human bile and serum levels by high pressure liquid chromatography after administration of latamoxef or cefotaxime. Arzneimittel-Forschung/Drug Research 34: 1787–1791, 1984

    Google Scholar 

  • Kunz J, Lüthy R. Empfehlungen zur systemischen perioperativen Infektions-prophylaxe in der Gynäkologie und Geburtshilfe. Schweizerische Medizinische Wochenschrift 114: 956–960, 1984

    PubMed  CAS  Google Scholar 

  • Lacey RW. Bacteriological aspects of antibiotic prophylaxis with hysterectomy. Journal of Obstetrics and Gynecology 5 (Suppl. 1): S24–S25, 1984

    Article  Google Scholar 

  • Lin T-Y, et al. Seven days of ceftriaxone therapy is as effective as ten days’ treatment for bacterial meningitis. Journal of the American Medical Association 253: 3559–3563, 1985

    Article  PubMed  CAS  Google Scholar 

  • Louie TJ, et al. Cefotaxime, cefazolin, or ampicillin prophylaxis of febrile morbidity in emergency cesarian sections. Clinical Therapeutics 5 (Suppl. A): 83–96, 1982

    PubMed  Google Scholar 

  • Luscher KP, Bruhwiler H. Perioperative Antibiotikaprophylaxe bei Hysterektomien. Prospektive randomisierte Studie zur Wirksamkeit einer Einmaldosis von Ceftriaxon. Schweizerische Rundshau für Medizin Praxis 74: 593–597, 1985

    CAS  Google Scholar 

  • McDonald P-J, et al. Antibiotic prophylaxis in hysterectomy — cefotaxime compared to ampicillin-tinidazole. Journal of Antimicrobial Chemotherapy 14 (Suppl. B): 223–230, 1984

    PubMed  Google Scholar 

  • Meguro H, et al. Clinical and pharmacokinetic study on ceftriaxone in pediatric bacterial infections. Japanese Journal of Antibiotics 37: 2049–2059, 1984

    PubMed  CAS  Google Scholar 

  • Naber K, Adam D. Pharmakokinetik von Cefotaxim bei geriatrischen Patienten. Münchener Medizinische Wochenschrift 122: 1651–1654, 1980

    PubMed  CAS  Google Scholar 

  • Nilsson-Ehle I, et al. Ceftriaxone: Pharmacokinetics and effect on the intestinal microflora in patients with acute bacterial infections. Scandinavian Journal of Infectious Diseases 17: 77–82, 1985

    Article  PubMed  CAS  Google Scholar 

  • Norrby SR. Problems in evaluation of adverse reactions to β-lactam antibiotics. Reviews of Infectious Diseases 8 (Suppl. 3): S358–S370, 1986

    Article  PubMed  Google Scholar 

  • Periti P, et al. Single-dose ceftriaxone versus multi-dose cefotaxime antimicrobial prophylaxis in gynecologic and obstetrical surgery. Preliminary results of a multicenter prospective randomized study. Chemioterapia 3: 299–304, 1984

    PubMed  CAS  Google Scholar 

  • Perri G, et al. Comparative prospective study on antibiotic prophylaxis in hysterectomy. Giornale Italiano Obstetrica Ginecologia 8: 31–35, 1986

    Google Scholar 

  • Petersen C, Bräutigam HH. Perioperative Kurzzeitprophylaxe mit Cefotaxim in der operativen Frauenheilkunde. Deutsche Medizinische Wochenschrift 110: 1369–1374, 1985

    Article  PubMed  CAS  Google Scholar 

  • Petersen EE, et al. Antibiotika-Prophylaxe bei Hysterektomie. Studie über die Wirsamkeit der einmaligen präoperativen Gabe von Ceftriaxon. Geburtshilfe und Frauenheilkunde 43: 492–497, 1983

    Article  PubMed  CAS  Google Scholar 

  • Roy S, Wilkins J. Comparison of cefotaxime with cefazolin for prophylaxis of vaginal or abdominal hysterectomy. Clinical Therapeutics 5 (Suppl. A): 74–82, 1982

    PubMed  Google Scholar 

  • Roy S, Wilkins J. Single-dose cefotaxime versus 3 to 5 dose cefoxitin for prophylaxis of vaginal or abdominal hysterectomy. Journal of Antimicrobial Chemotherapy 14 (Suppl. B): 217–221, 1984

    PubMed  Google Scholar 

  • Seddan M, et al. Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy 18: 240–242, 1980

    Article  Google Scholar 

  • Shyu WC, et al. Biliary excretion of cefotaxime. Current Therapeutic Research, Clinical and Experimental 35: 727–734, 1984

    Google Scholar 

  • Vogelman BS, Craig A. The pharmacokinetics of the third-generation cephalosporins in man: a review. In Klastersky (Ed.) Nosocomial infections: Current problems and the use of cephalosporins 1983 update, pp. 52–70, Service de Médicine Interne, Institut Jules Bordet, Centre des Tumeurs de l’Université Libre de Bruxelles, Brussels, 1983

  • Wideman GL, Matthisjssen C. Comparative efficacy of cefotaxime and cefazolin as prophylaxis against infections following elective hysterectomy. Clinical Therapeutics 5 (Suppl. A): 67–73, 1982

    PubMed  Google Scholar 

  • Wise R, et al. Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease. Antimicrobial Agents and Chemotherapy 19: 526–531, 1981

    Article  PubMed  CAS  Google Scholar 

  • Yogev R, et al. Once daily ceftriaxone for central nervous system infections and other serious pediatric infections. Pediatric Infectious Disease 5: 298–303, 1986

    Article  PubMed  CAS  Google Scholar 

  • Young JPW, Husson JM, Bruch K, Blomer RJ, Savopoulos C. The evaluation of effficacy and safety of cefotaxime: a review of 2500 cases. Journal of Antimirobial Chemotherapy 6 (Suppl. A): 293–300, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynaecology, Marienhospital, Hamburg, Germany

    H. H. Bräutigam

  2. University of Frankfurt, Frankfurt, Germany

    H. Knothe & R. Rangoonwala

Authors
  1. H. H. Bräutigam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Knothe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Rangoonwala
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bräutigam, H.H., Knothe, H. & Rangoonwala, R. Impact of Cefotaxime and Ceftriaxone on the Bowel and Vaginal Flora after Single-Dose Prophylaxis in Vaginal Hysterectomy. Drugs 35 (Suppl 2), 163–168 (1988). https://doi.org/10.2165/00003495-198800352-00035

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800352-00035

Keywords

Search

Navigation